D.D. Pharmaceuticals Pvt. Ltd

D.D. Pharmaceuticals Pvt. Ltd - pharma in Jaipur, Rajasthan, India. FY 2026 financials & compliance.
CIN U24232RJ1994PTC008661 Incorporated 12 August 1994 ROC Jaipur HQ Jaipur, Rajasthan, India
Active Private Limited Company pharma MSME · Small
Data last updated
Revenue · FY 2024
₹85.6 Cr
▲ 20% YoY
Net profit · FY 2024
₹5.16 Cr
Net margin 6%
EBITDA · FY 2024
₹10.38 Cr
EBITDA margin 12.1%
Authorised capital
₹40 Lakh
Registered with MCA
Paid-up capital
₹36.03 Lakh
Issued & subscribed
Open charges
₹24.64 Cr
Satisfied ₹30.52 Cr
Company age
32 yrs
Est. 1994
Employees · EPFO
252
Provident fund records

About D.D. Pharmaceuticals Pvt. Ltd

Data last updated:

D.D. Pharmaceuticals Pvt. Ltd is a private limited company based in Jaipur, Rajasthan, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 12 August 1994 and has been in existence for over 32 years.

The company is registered with the Registrar of Companies (ROC), Jaipur, under CIN U24232RJ1994PTC008661. Its GSTIN is 08AAACD4394D1ZS (Rajasthan).

The company has an authorised share capital of ₹40 Lakh and a paid-up capital of ₹36.03 Lakh. It is led by directors including Lalita Choudhary (Whole-Time Director) and Amit Kumar Choudhary (Whole-Time Director).

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at G – 1/583 RIICO Industrial Area Sitapura Tonk Road Jaipur. Sitapura Tonk Road Jaipur., Rajasthan, India.

As per the financials filed for FY 2024, the company reported a revenue of ₹85.6 Cr, a growth of 20% compared to the previous year. For the same year it recorded a net profit of ₹5.16 Cr (net margin 6%) and EBITDA of ₹10.38 Cr (EBITDA margin 12.1%). Revenue has grown at a compounded annual rate (CAGR) of 24% over three years and 19% over five years.

The company has about 252 employees on its provident fund (EPFO) records.

The company is associated with 1 brand: DD Pharmaceuticals. As per MCA filings, the company has open charges of ₹24.64 Cr and satisfied charges of ₹30.52 Cr on record. Court records list 14 cases involving the company, including 4 filed by the company and 8 filed against it; 3 cases are pending.

D.D. Pharmaceuticals Pvt. Ltd is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-RJ-17-0000539). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website ddpharmapvtltd.com.

Company Details of D.D. Pharmaceuticals Pvt. Ltd
CIN U24232RJ1994PTC008661
Registration Number 008661
Incorporation Date 12 August 1994
ROC Jaipur
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-RJ-17-0000539

Recognitions & Rankings of D.D. Pharmaceuticals

MSME (Udyam registered) Ministry of MSME
Category
Small (2022-23)
Udyam number
UDYAM-RJ-17-0000539
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Social Media
    Locked
  • Registered Address
    G – 1/583 RIICO Industrial Area Sitapura Tonk Road Jaipur. Sitapura Tonk Road Jaipur., Rajasthan, India
  • Industry
    Pharma, Drug Formulation & Development
Comprehensive company report
D.D. Pharmaceuticals Pvt. Ltd - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
  • One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Unlock the full D.D. Pharmaceuticals Pvt. Ltd report

Financials, compliance, directors, charges, ownership and filings for D.D. Pharmaceuticals Pvt. Ltd in one report.

Financials from 2015 Directors & ownership Charges & compliance

Associated Brands with D.D. Pharmaceuticals Pvt. Ltd

D.D. Pharmaceuticals operates one associated brand: DD Pharmaceuticals. Each brand links to its own profile.

BrandDescriptionWebsite
Manufactures and markets a wide range of healthcare products.ddpharmapvtltd.com

Business Activity of D.D. Pharmaceuticals Pvt. Ltd

The main business activity of D.D. Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main Activity Group CodeDescription of Main ActivityBusiness Activity CodeDescription of Business ActivityTurnover Percentage
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical productsLocked
Premium access

Business activity turnover details

Turnover share and past changes in activity are in the company report.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Financials of D.D. Pharmaceuticals Pvt. Ltd FY 2025 filings available

D.D. Pharmaceuticals Pvt. Ltd reported revenue of ₹85.6 Cr (up 20% YoY) for FY 2024.

Revenue · FY 2024
₹85.6 Cr ▲ 20%
Net profit · FY 2024
₹5.16 Cr margin 6%
EBITDA · FY 2024
₹10.38 Cr margin 12.1%

Compounded Annual Growth Rate (CAGR) of D.D. Pharmaceuticals Pvt. Ltd

Revenue CAGR growth
1 year
▲ 20%
3 years · compounded
▲ 24%
5 years · compounded
▲ 19%
EBITDA CAGR growth
1 year
▲ 59%
3 years · compounded
▲ 34%
5 years · compounded
▲ 18%

Revenue has grown at a compounded annual rate (CAGR) of 19% over five years, including 20% growth in the latest year. EBITDA rose 59% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary of D.D. Pharmaceuticals Pvt. Ltd

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profit and Loss Statement
Revenue from Operations••••••••••••••••••••
Other Income••••••••••••••••••••
Total Revenue••••••••••••••••••••
Cost of Materials Consumed••••••••••••••••••••
Employee Benefit Expense••••••••••••••••••••
Finance Costs••••••••••••••••••••
Depreciation and Amortisation••••••••••••••••••••
Other Expenses••••••••••••••••••••
Total Expenses••••••••••••••••••••
EBITDA₹10.38 Cr••••••••••••••••
Profit Before Tax••••••••••••••••••••
Tax Expense••••••••••••••••••••
Net Profit (PAT)₹5.16 Cr••••••••••••••••
Balance Sheet
Share Capital••••••••••••••••••••
Reserves and Surplus••••••••••••••••••••
Net Worth (Total Equity)••••••••••••••••••••
Long-term Borrowings••••••••••••••••••••
Short-term Borrowings••••••••••••••••••••
Trade Payables••••••••••••••••••••
Total Liabilities••••••••••••••••••••
Fixed Assets••••••••••••••••••••
Investments••••••••••••••••••••
Inventories••••••••••••••••••••
Trade Receivables••••••••••••••••••••
Cash and Bank Balance••••••••••••••••••••
Total Assets••••••••••••••••••••

Financial Ratios of D.D. Pharmaceuticals Pvt. Ltd

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profitability
EBITDA Margin12.1%••••••••••••••••
Net Profit Margin6%••••••••••••••••
Return on Equity (ROE)••••••••••••••••••••
Return on Capital Employed (ROCE)••••••••••••••••••••
Return on Assets (ROA)••••••••••••••••••••
Liquidity and Debt
Current Ratio••••••••••••••••••••
Quick Ratio••••••••••••••••••••
Debt-to-Equity Ratio••••••••••••••••••••
Interest Coverage Ratio••••••••••••••••••••
Efficiency and Growth
Asset Turnover••••••••••••••••••••
Receivable Days••••••••••••••••••••
Payable Days••••••••••••••••••••
Inventory Days••••••••••••••••••••
Revenue Growth••••••••••••••••••••
Net Profit Growth••••••••••••••••••••

Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of D.D. Pharmaceuticals are in the company report.

Premium access

Financial statements from 2015

Earlier years and trend charts are in the company report.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Board of Directors of D.D. Pharmaceuticals Pvt. Ltd

D.D. Pharmaceuticals has 3 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Lalita ChoudharyWhole-Time Director12 Aug 199432 Years 2 MonthsCurrent
Amit Kumar ChoudharyWhole-Time Director22 Jun 200125 Years 3 MonthsCurrent
Alka ChoudharyWhole-Time Director10 Mar 201412 Years 7 MonthsCurrent

Peer Comparison of D.D. Pharmaceuticals Pvt. Ltd

D.D. Pharmaceuticals Pvt. Ltd is compared with the companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Safecon Lifesciences Private Limited₹87 Cr (FY 2025)••••••••59.0%••••Agra, Uttar Pradesh, India
Health Biotech Limited₹86.89 Cr (FY 2025)••••••••-22.0%••••Chandigarh, India
Shree Maruti Nandan Pharmaceuticals Private Limited₹86.33 Cr (FY 2024)••••••••11.0%••••New Delhi, Delhi, India
Cyano Pharma Private Limited₹85.89 Cr (FY 2024)••••••••38.0%••••Mumbai, Maharashtra, India
Zenara Pharma Private Limited₹85.73 Cr (FY 2025)••••••••3.0%••••Hyderabad, Telangana, India
D.D. Pharmaceuticals Pvt. Ltd this company₹85.6 Cr (FY 2024)••••••••20.0%••••Jaipur, Rajasthan, India
Prachi Pharmaceuticals Private Limited₹85.43 Cr (FY 2024)••••••••-3.0%••••Mumbai, Maharashtra, India
Hema Pharmaceuticals Pvt Ltd₹85.23 Cr (FY 2025)••••••••17.0%••••Ankleshwar, Gujarat, India
Sidmak Laboratories (India) Private Limited₹85.07 Cr (FY 2025)••••••••-6.0%••••Valsad, Gujarat, India
Nava Healthcare Private Limited₹84.21 Cr (FY 2025)••••••••2.0%••••New Delhi, Delhi, India
Solvate Laboratories Private Limited₹84.09 Cr (FY 2025)••••••••8.0%••••Patna, Bihar, India

Peers are the five companies nearest above and the five nearest below D.D. Pharmaceuticals by revenue in the Pharma industry (Formulations, Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.

Auditor Details of D.D. Pharmaceuticals Pvt. Ltd

D.D. Pharmaceuticals Pvt. Ltd is audited by Bargoti Mantri & Company for the financial year 2022.

NameStatusAppointment DateCessation Date
Bargoti Mantri & CompanyLockedLockedLocked
Premium access

Complete auditor history

Appointment and cessation dates and past auditor changes are in the company report.

  • Appointment status
  • Appointment dates
  • Cessation dates
  • Auditor changes

Verified entity values are shown only after access is granted.

Ownership and Shareholding of D.D. Pharmaceuticals Pvt. Ltd

Premium access

Shareholding and ownership data

Promoter, institutional, public and beneficial ownership figures are in the company report.

  • Ownership categories
  • Historical changes
  • Group structure
  • FII and DII holdings

Verified entity values are shown only after access is granted.

Charges & Borrowings of D.D. Pharmaceuticals Pvt. Ltd

Open charges
₹24.64 Cr
Satisfied charges
₹30.52 Cr
Breakdown by lending institutions
Others₹24.64 Cr
Latest charge details
DateLenderAmountStatus
30 Jul 2024Others₹5.56 CrOpen
22 May 2024Others₹3.5 CrOpen
27 Jul 2021Others₹67.5 LakhOpen
27 Jun 2016Others₹14.9 CrOpen
03 Sep 2022Others₹12.9 CrSatisfied

Total charge records: 12 View all charges

Employees and EPFO Compliance at D.D. Pharmaceuticals Pvt. Ltd

D.D. Pharmaceuticals Pvt. Ltd has a workforce of 252 employees as of Mar 28, 2024.

Employee count
252
Active EPFO establishments
1
Employee growth
13.51%
Premium access

Employee and EPFO history

Monthly headcount, contribution history and filing status are in the company report.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

Recent Activity on D.D. Pharmaceuticals Pvt. Ltd

D.D. Pharmaceuticals Pvt. Ltd has 7 board changes on record since 1994: 3 appointments and 4 cessations. The latest: Alka Choudhary ceased to be Additional Director on 30 Sep 2014.

Charges
A charge with Others of Rs. 1,490.00 Lakh registered on 27 Jun 2016 with Charge ID 100053834 was modified on 28 Oct 2025.
AGM
D.D. Pharmaceuticals Pvt. Ltd last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Charges
A charge registered on 15 Dec 2021 via Charge ID 100518521 with Others was fully satisfied on 18 Jun 2025.
Charges
A charge registered on 04 Feb 2022 via Charge ID 100538440 with Others was fully satisfied on 13 Jun 2025.
Filing
D.D. Pharmaceuticals Pvt. Ltd has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Jaipur.
Charges
A charge with Others amounted to Rs. 556.28 Lakh with Charge ID 100956811 was registered on 30 Jul 2024.
Charges
A charge with Others amounted to Rs. 350.00 Lakh with Charge ID 100923858 was registered on 22 May 2024.
Charges
A charge registered on 03 Sep 2022 via Charge ID 100606258 with Others was fully satisfied on 13 Mar 2024.
Charges
A charge with Others of Rs. 1,289.77 Lakh registered on 03 Sep 2022 with Charge ID 100606258 was modified on 29 Apr 2023.
Charges
A charge with Others amounted to Rs. 1,289.77 Lakh with Charge ID 100606258 was registered on 03 Sep 2022.
Charges
A charge with Others amounted to Rs. 44.80 Lakh with Charge ID 100538440 was registered on 04 Feb 2022.
Charges
A charge with Others amounted to Rs. 65.00 Lakh with Charge ID 100518521 was registered on 15 Dec 2021.

20 earlier events are listed in the company report.

Credit Ratings, Litigation & Regulatory Alerts for D.D. Pharmaceuticals Pvt. Ltd

Premium access

Credit ratings, litigation, and regulatory alerts

Credit ratings, court records and regulatory alerts are in the company report.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by D.D. Pharmaceuticals Pvt. Ltd

Premium access

MSME payment history

Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of D.D. Pharmaceuticals Pvt. Ltd

Premium access

Corporate group structure

Parent, subsidiary, associate and joint venture records with holdings are in the company report.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

GST Compliance of D.D. Pharmaceuticals Pvt. Ltd

D.D. Pharmaceuticals has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
08AAACD4394D1ZSRajasthanActive01 Jul 2017
Premium access

GST registrations and filing compliance

State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

MCA Filings & Documents of D.D. Pharmaceuticals Pvt. Ltd

Premium access

MCA filings and documents

Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Frequently Asked Questions about D.D. Pharmaceuticals Pvt. Ltd

D.D. Pharmaceuticals is an active private limited company based in Jaipur, Rajasthan, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 12 August 1994 (32+ years old) and is registered under CIN U24232RJ1994PTC008661.

D.D. Pharmaceuticals reported revenue of ₹85.6 Cr for FY 2024 (up 20% YoY).

D.D. Pharmaceuticals has 3 current directors:

D.D. Pharmaceuticals reported a net profit of ₹5.16 Cr (net margin 6%) and EBITDA of ₹10.38 Cr (EBITDA margin 12.1%) for FY 2024, as per its filed financial statements.

The compounded annual growth rate (CAGR) of the revenue of D.D. Pharmaceuticals is 24% over three years and 19% over five years. In the latest year (FY 2024) revenue rose 20%. CAGR is the steady yearly rate that links the first and the last year.

The GSTIN of D.D. Pharmaceuticals is 08AAACD4394D1ZS, registered in Rajasthan.

The CIN (Corporate Identification Number) of D.D. Pharmaceuticals is U24232RJ1994PTC008661. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

D.D. Pharmaceuticals has 14 court cases on record: 4 filed by the company and 8 filed against it. 3 are pending. Most are in the high courts.

D.D. Pharmaceuticals was incorporated on 12 August 1994, making it 32+ years old. It is registered with the Registrar of Companies, Jaipur.

The peers of D.D. Pharmaceuticals by revenue are Safecon Lifesciences Private Limited, Health Biotech Limited, Shree Maruti Nandan Pharmaceuticals Private Limited, Cyano Pharma Private Limited, Zenara Pharma Private Limited and 5 more, all in the Pharma industry (Formulations, Pharmaceuticals).

Alka Choudhary ceased to be Additional Director on 30 Sep 2014. Alka Choudhary was appointed as Whole-Time Director on 10 Mar 2014. Prakash Kumar Choudhary ceased to be Whole-Time Director on 23 Feb 2014. D.D. Pharmaceuticals has 7 board changes on record in total.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - compiled from official filings and updated regularly.

Subscription plans available